DexCom Inc.

393.04-7.00-1.75%Vol 381.17K1Y Perf 21.17%
Apr 19th, 2021 16:00 DELAYED
BID393.04 ASK394.00
Open396.60 Previous Close400.04
Pre-Market- After-Market393.04
 - -  - -%
Target Price
456.39 
Analyst Rating
Strong Buy 1.45
Potential %
16.12 
Finscreener Ranking
★★★★     53.92
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★     51.20
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★★     77.04
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap38.01B 
Earnings Rating
Strong Sell
Price Range Ratio 52W %
58.04 
Earnings Date
29th Apr 2021

Today's Price Range

391.64399.01

52W Range

305.63456.23

5 Year PE Ratio Range

-86.50418.60

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
1.27%
1 Month
14.05%
3 Months
7.94%
6 Months
0.16%
1 Year
21.17%
3 Years
442.35%
5 Years
486.10%
10 Years
2 270.57%

TickerPriceChg.Chg.%
DXCM393.04-7.0000-1.75
AAPL134.840.68000.51
GOOG2 302.404.64000.20
MSFT258.74-2.0000-0.77
XOM56.48-0.1800-0.32
WFC43.880.04000.09
JNJ162.690.45000.28
FB302.24-3.9400-1.29
GE13.460.07000.52
JPM152.65-0.6500-0.42
Financial StrengthValueIndustryS&P 500US Markets
5.10
5.60
0.50
1.01
3.70
Leverage Ratio 2.50
ProfitabilityValueIndustryS&P 500US Markets
66.40
16.10
19.60
-2.30
31.91
RevenueValueIndustryS&P 500US Markets
1.52B
15.73
36.98
35.07
Earnings HistoryEstimateReportedSurprise %
Q04 20200.910.910.00
Q03 20200.640.9446.88
Q02 20200.310.79154.84
Q01 20200.100.44340.00
Q04 20190.751.1553.33
Q03 20190.180.65261.11
Q02 20190.000.08-
Q01 2019-0.17-0.0570.59
Earnings Per EndEstimateRevision %Trend
3/2021 QR0.31-38.00Negative
6/2021 QR0.48-30.43Negative
12/2021 FY2.26-31.72Negative
12/2022 FY3.33-19.17Negative
Next Report Date29th Apr 2021
Estimated EPS Next Report0.31
Estimates Count12
EPS Growth Next 5 Years %17.80
Volume Overview
Volume381.17K
Shares Outstanding96.71M
Trades Count12.43K
Dollar Volume263.15M
Avg. Volume822.91K
Avg. Weekly Volume465.61K
Avg. Monthly Volume622.57K
Avg. Quarterly Volume773.38K

DexCom Inc. (NASDAQ: DXCM) stock closed at 393.04 per share at the end of the most recent trading day (a -1.75% change compared to the prior day closing price) with a volume of 389.74K shares and market capitalization of 38.01B. Is a component of S&P 500, NASDAQ 100, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 6400 people. DexCom Inc. CEO is Kevin R. Sayer.

The one-year performance of DexCom Inc. stock is 21.17%, while year-to-date (YTD) performance is 6.31%. DXCM stock has a five-year performance of 486.1%. Its 52-week range is between 305.63 and 456.23, which gives DXCM stock a 52-week price range ratio of 58.04%

DexCom Inc. currently has a PE ratio of 79.20, a price-to-book (PB) ratio of 21.18, a price-to-sale (PS) ratio of 24.98, a price to cashflow ratio of 82.00, a PEG ratio of 2.32, a ROA of 14.31%, a ROC of 10.89% and a ROE of 35.42%. The company’s profit margin is 31.91%, its EBITDA margin is 19.60%, and its revenue ttm is $1.52 Billion , which makes it $15.73 revenue per share.

Of the last four earnings reports from DexCom Inc., there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.31 for the next earnings report. DexCom Inc.’s next earnings report date is 29th Apr 2021.

The consensus rating of Wall Street analysts for DexCom Inc. is Strong Buy (1.45), with a target price of $456.39, which is +16.12% compared to the current price. The earnings rating for DexCom Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

DexCom Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

DexCom Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 16.45, ATR14 : 14.10, CCI20 : 109.02, Chaikin Money Flow : 0.31, MACD : 0.52, Money Flow Index : 80.74, ROC : 9.36, RSI : 45.71, STOCH (14,3) : 85.74, STOCH RSI : 0.61, UO : 70.78, Williams %R : -14.26), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of DexCom Inc. in the last 12-months were: Andrew K. Balo (Sold 21 674 shares of value $8 231 009 ), Barbara E. Kahn (Sold 9 800 shares of value $3 732 696 ), Bridgette P. Heller (Sold 375 shares of value $133 744 ), Donald Abbey (Sold 25 071 shares of value $10 008 614 ), Jake Leach (Sold 28 342 shares of value $10 687 167 ), Jereme M. Sylvain (Sold 3 662 shares of value $1 360 174 ), Kevin R. Sayer (Sold 174 247 shares of value $62 940 042 ), Mark G. Foletta (Sold 3 000 shares of value $1 132 274 ), Nicholas Augustinos (Sold 9 375 shares of value $3 574 635 ), Patrick Michael Murphy (Sold 20 513 shares of value $7 592 094 ), Quentin S. Blackford (Sold 31 588 shares of value $12 374 549 ), Richard B. Doubleday (Sold 28 505 shares of value $10 883 605 ), Richard Doubleday (Sold 16 102 shares of value $6 285 462 ), Shelly Ramasamy Selvaraj (Sold 12 121 shares of value $4 696 524 ), Steven R. Altman (Sold 42 000 shares of value $16 850 599 ), Steven R. Pacelli (Sold 50 473 shares of value $19 455 781 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
15 (75.00 %)
15 (78.95 %)
15 (78.95 %)
Moderate Buy
1 (5.00 %)
1 (5.26 %)
1 (5.26 %)
Hold
4 (20.00 %)
3 (15.79 %)
3 (15.79 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.45
Strong Buy
1.37
Strong Buy
1.37

DexCom Inc.

DexCom Inc designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.

CEO: Kevin R. Sayer

Telephone: +1 858 200-0200

Address: 6340 Sequence Drive, San Diego 92121, CA, US

Number of employees: 6 400

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

53%48%

Bearish Bullish

49%51%

Bearish Bullish

60%40%

News

Stocktwits